These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies? de Boer WB, Segal A, Frost FA, Sterrett GF. Cancer; 2000 Oct 25; 90(5):273-8. PubMed ID: 11038423 [Abstract] [Full Text] [Related]
6. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades. Lin CC, Lin CJ, Hsu CW, Chen YC, Chen WT, Lin SM. J Gastroenterol Hepatol; 2008 Jul 25; 23(7 Pt 2):e146-52. PubMed ID: 17532784 [Abstract] [Full Text] [Related]
7. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy? Wee A, Nilsson B. Acta Cytol; 2003 Jul 25; 47(1):16-26. PubMed ID: 12585026 [Abstract] [Full Text] [Related]
15. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors. Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN. Indian J Pathol Microbiol; 2006 Jul 25; 49(3):341-4. PubMed ID: 17001880 [Abstract] [Full Text] [Related]
16. Cytodiagnosis of well differentiated hepatocellular carcinoma: can indeterminate diagnoses be reduced? de Boer WB, Segal A, Frost FA, Sterrett GF. Cancer; 1999 Oct 25; 87(5):270-7. PubMed ID: 10536352 [Abstract] [Full Text] [Related]